J. David Enloe, Jr
2021
In 2021, J. David Enloe, Jr earned a total compensation of $1.1M as President and Chief Executive Officer at Recro Pharma, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $377,190 |
|---|---|
| Salary | $550,000 |
| Stock Awards | $120,793 |
| Other | $49,062 |
| Total | $1,097,045 |
Enloe received $550K in salary, accounting for 50% of the total pay in 2021.
Enloe also received $377.2K in non-equity incentive plan, $120.8K in stock awards and $49.1K in other compensation.
Rankings
In 2021, J. David Enloe, Jr's compensation ranked 8,467th out of 12,415 executives tracked by ExecPay. In other words, Enloe earned more than 31.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,467 out of 12,415 | 32nd |
Division Manufacturing | 3,753 out of 5,508 | 32nd |
Major group Chemicals And Allied Products | 1,660 out of 2,378 | 30th |
Industry group Drugs | 1,478 out of 2,099 | 30th |
Industry Pharmaceutical Preparations | 1,101 out of 1,549 | 29th |
Source: SEC filing on April 1, 2022.
Enloe's colleagues
We found one more compensation record of an executive who worked with J. David Enloe, Jr at Recro Pharma in 2021.
2021
Ryan Lake
Recro Pharma